BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10741902)

  • 1. An assessment of the acute effects of the serotonin releasers methylenedioxymethamphetamine, methylenedioxyamphetamine and fenfluramine on immunity in rats.
    Connor TJ; Kelly JP; Leonard BE
    Immunopharmacology; 2000 Mar; 46(3):223-35. PubMed ID: 10741902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro.
    Setola V; Hufeisen SJ; Grande-Allen KJ; Vesely I; Glennon RA; Blough B; Rothman RB; Roth BL
    Mol Pharmacol; 2003 Jun; 63(6):1223-9. PubMed ID: 12761331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal ACTH and prolactin responses to fenfluramine in rats exposed to single and multiple doses of MDMA.
    Poland RE; Lutchmansingh P; McCracken JT; Zhao JP; Brammer GL; Grob CS; Boone KB; Pechnick RN
    Psychopharmacology (Berl); 1997 Jun; 131(4):411-9. PubMed ID: 9226745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of glucoprivation on serotonin neurotoxicity induced by substituted amphetamines.
    Yuan J; Cord BJ; McCann UD; Callahan BT; Ricaurte GA
    J Pharmacol Exp Ther; 2002 Nov; 303(2):831-9. PubMed ID: 12388670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of (+)-methamphetamine, ±-methylenedioxymethamphetamine, (+)-amphetamine and ±-fenfluramine in rats on egocentric learning in the Cincinnati water maze.
    Vorhees CV; He E; Skelton MR; Graham DL; Schaefer TL; Grace CE; Braun AA; Amos-Kroohs R; Williams MT
    Synapse; 2011 May; 65(5):368-78. PubMed ID: 20730798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine.
    Crespi D; Mennini T; Gobbi M
    Br J Pharmacol; 1997 Aug; 121(8):1735-43. PubMed ID: 9283711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of (+)-fenfluramine on 3,4-methylenedioxymethamphetamine (MDMA) discrimination in rats.
    Baker LE; Makhay MM
    Pharmacol Biochem Behav; 1996 Feb; 53(2):455-61. PubMed ID: 8808158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release of serotonin induced by 3,4-methylenedioxymethamphetamine (MDMA) and other substituted amphetamines in cultured fetal raphe neurons: further evidence for calcium-independent mechanisms of release.
    Wichems CH; Hollingsworth CK; Bennett BA
    Brain Res; 1995 Oct; 695(1):10-8. PubMed ID: 8574641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerance to 3,4-methylenedioxymethamphetamine is associated with impaired serotonin release.
    Jones K; Brennan KA; Colussi-Mas J; Schenk S
    Addict Biol; 2010 Jul; 15(3):289-98. PubMed ID: 20477756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylenedioxymethamphetamine (MDMA; Ecstasy) suppresses IL-1beta and TNF-alpha secretion following an in vivo lipopolysaccharide challenge.
    Connor TJ; Kelly JP; McGee M; Leonard BE
    Life Sci; 2000 Aug; 67(13):1601-12. PubMed ID: 10983854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reinforcing effects of certain serotonin-releasing amphetamine derivatives.
    Marona-Lewicka D; Rhee GS; Sprague JE; Nichols DE
    Pharmacol Biochem Behav; 1996 Jan; 53(1):99-105. PubMed ID: 8848466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thioether metabolites of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine inhibit human serotonin transporter (hSERT) function and simultaneously stimulate dopamine uptake into hSERT-expressing SK-N-MC cells.
    Jones DC; Lau SS; Monks TJ
    J Pharmacol Exp Ther; 2004 Oct; 311(1):298-306. PubMed ID: 15169827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine.
    Berger UV; Gu XF; Azmitia EC
    Eur J Pharmacol; 1992 May; 215(2-3):153-60. PubMed ID: 1356787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype.
    Colado MI; Williams JL; Green AR
    Br J Pharmacol; 1995 Aug; 115(7):1281-9. PubMed ID: 7582557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain.
    Steele TD; Nichols DE; Yim GK
    Biochem Pharmacol; 1987 Jul; 36(14):2297-303. PubMed ID: 2886126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute 3,4-methylenedioxymethamphetamine(MDMA) administration produces a rapid and sustained suppression of immune function in the rat.
    Connor TJ; McNamara MG; Finn D; Currid A; O'Malley M; Redmond AM; Kelly JP; Leonard BE
    Immunopharmacology; 1998 Jan; 38(3):253-60. PubMed ID: 9506825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MDMA (ecstasy) inhibition of MAO type A and type B: comparisons with fenfluramine and fluoxetine (Prozac).
    Leonardi ET; Azmitia EC
    Neuropsychopharmacology; 1994 Jul; 10(4):231-8. PubMed ID: 7945733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the serotonin releasers 3,4-methylenedioxymethamphetamine (MDMA), 4-chloroamphetamine (PCA) and fenfluramine on acoustic and tactile startle reflexes in rats.
    Kehne JH; McCloskey TC; Taylor VL; Black CK; Fadayel GM; Schmidt CJ
    J Pharmacol Exp Ther; 1992 Jan; 260(1):78-89. PubMed ID: 1731054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma levels of parent compound and metabolites after doses of either d-fenfluramine or d-3,4-methylenedioxymethamphetamine (MDMA) that produce long-term serotonergic alterations.
    Bowyer JF; Young JF; Slikker W; Itzak Y; Mayorga AJ; Newport GD; Ali SF; Frederick DL; Paule MG
    Neurotoxicology; 2003 Jun; 24(3):379-90. PubMed ID: 12782103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine.
    Colado MI; Murray TK; Green AR
    Br J Pharmacol; 1993 Mar; 108(3):583-9. PubMed ID: 7682129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.